Cargando…
Gut microbiota and pro/prebiotics in Alzheimer’s disease
Alzheimer’s disease is characterized by the accumulation of amyloid and dysfunctional tau protein in the brain along with the final development of dementia. Accumulation of amyloid in the brain was observed 10-20 years before the onset of clinical symptoms by diagnostic methods based on image analys...
Autores principales: | Pluta, Ryszard, Ułamek-Kozioł, Marzena, Januszewski, Sławomir, Czuczwar, Stanisław J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138569/ https://www.ncbi.nlm.nih.gov/pubmed/32191919 http://dx.doi.org/10.18632/aging.102930 |
Ejemplares similares
-
Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer’s Disease to Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020) -
Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer’s Disease after Ischemia-Reperfusion Brain Injury
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2020) -
Mutual Two-Way Interactions of Curcumin and Gut Microbiota
por: Pluta, Ryszard, et al.
Publicado: (2020) -
Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia
por: Pluta, Ryszard, et al.
Publicado: (2020) -
Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2020)